Avantor (AVTR)
Supplies laboratory and bioproduction workflows from research through production.
$14.92
vs last close−0.03 (−0.17%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,720 | 1,723 | 1,680 | 1,703 | 1,714 | 1,687 | 1,581 | 1,683 | 1,624 | 1,664 | 1,581 | 1,692 |
| Cost of revenue | 1,142 | 1,152 | 1,109 | 1,121 | 1,150 | 1,124 | 1,047 | 1,129 | 1,097 | 1,140 | 1,081 | 1,155 |
| Gross profit | 579 | 570 | 571 | 582 | 564 | 563 | 535 | 554 | 527 | 524 | 501 | 537 |
| 368 | 387 | 424 | 406 | 440 | −75 | 388 | 425 | 1,175 | 398 | 386 | 415 | |
| Selling, general & administrative | 368 | 387 | 424 | 406 | 440 | 371 | 388 | 425 | 390 | 392 | 0 | 415 |
| Other expenses | 0 | 0 | 0 | 0 | 0 | −447 | 0 | 0 | 785 | 5 | 386 | 0 |
| Operating income | 210 | 183 | 146 | 176 | 125 | 638 | 147 | 129 | −649 | 126 | 115 | 122 |
| −74 | −64 | −66 | −61 | −50 | −54 | −62 | −47 | −41 | −46 | −60 | −41 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11 | 0 |
| Interest expense | 72 | 65 | 64 | 61 | 49 | 45 | 42 | 43 | 44 | 40 | 55 | 39 |
| Other non-operating income | 1 | −2 | 1 | 0 | 1 | 9 | 20 | 4 | −4 | 6 | 4 | 1 |
| Income before tax | 137 | 120 | 81 | 115 | 75 | 584 | 86 | 82 | −690 | 81 | 56 | 81 |
| Income tax expense | 28 | 21 | 20 | 22 | 17 | 84 | 21 | 17 | 22 | 28 | 12 | 43 |
| Net income from continuing operations | 108 | 99 | 60 | 93 | 58 | 500 | 65 | 65 | −712 | 52 | 43 | 38 |
| Net income | 108 | 99 | 60 | 93 | 58 | 500 | 65 | 65 | −712 | 52 | 43 | 38 |
| EPS, basic | $0.16 | $0.15 | $0.09 | $0.14 | $0.09 | $0.74 | $0.09 | $0.09 | −$1.04 | $0.08 | $0.06 | $0.06 |
| EPS, diluted | $0.16 | $0.15 | $0.09 | $0.14 | $0.08 | $0.73 | $0.09 | $0.09 | −$1.04 | $0.08 | $0.06 | $0.06 |
| Weighted average shares, basic | 676 | 676 | 678 | 679 | 680 | 681 | 681 | 682 | 682 | 678 | 678 | 676 |
| Weighted average shares, diluted | 679 | 679 | 681 | 683 | 683 | 683 | 682 | 682 | 682 | 679 | 679 | 677 |
| EBITDA | 307 | 285 | 245 | 278 | 226 | 730 | 228 | 228 | −541 | 224 | 216 | 226 |
| Depreciation & amortization | 98 | 101 | 100 | 103 | 102 | 101 | 100 | 103 | 105 | 103 | 105 | 106 |
| EBIT | 209 | 185 | 145 | 176 | 123 | 629 | 128 | 125 | −645 | 121 | 111 | 121 |